Dana Investment Advisors, Inc. Amicus Therapeutics, Inc. Transaction History

Dana Investment Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$8.71 - $10.72 $313,307 - $385,609	-35,971 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$9.2 - $23.86 $60,103 - $155,877	-6,533 Reduced 15.37%	35,971 $355,000
Q4 2020 Feb 11, 2021	SELL	$13.47 - $24.89 $152,035 - $280,933	-11,287 Reduced 20.98%	42,504 $981,000
Q3 2020 Nov 10, 2020	BUY	$12.89 - $15.89 $693,365 - $854,738	53,791 New	53,791 $760,000

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Dana Investment Advisors, Inc. with notifications on news.